Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth
Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded…
RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA and Revises Upwards 2024 Financial Guidance Ranges
Total Company Revenue increased 14.7% to $461.1 million in the third quarter…